YAP1 and cancer: Multiple pathways impact YAP/TAZ signaling and thereby limit expression of its targets which include cell proliferation, growth, stress response, immune evasion and survival genes that if deregulated, may help drive cancer initiation, growth, dissemination and therapy resistance [107,108,109,110].